The inhibition rate of IL-8 in the control and TBFS-containing serum groups increased with an increase in dexamethasone concentration, indicating that the drug-containing serum could enhance the anti-inflammatory effect of glucocorticoids and improve the resistance to glucocorticoids in the COPD model. This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.